Global Coverage Highlights Our Approach to Phase III Clinical Trials

As your compounds progress through early-phase trials, your therapies will enter Phase III clinical trials, where you’ll experience a significant increase in the number of patients and in the numbers of sites used. While some CROs can experience difficulties in adjusting to the larger volume of sites and patients, Datatrial is uniquely positioned to manage data in any and all Phase III studies.

Both our processes and our technology are scalable to accomodate Phase III clinical trials. Because we use the latest in .NET technologies, larger studies with vast amounts of data can easily be handled in our nowEDC software. Our hosting provider offers redundant power, processing and connections, so your large Phase III studies are always accessible from locations around the world. Perhaps most importantly, our people have experience delivering Phase III clinical trials and can contribute the right amount of resource to make your study a success.

Datatrial’s comprehensive global coverage, combined with our emphasis on customer service, allow us to support Phase III clinical trials in a variety of therapeutic areas. Because our nowEDC™ software can easily support patients and sites in many locations, unlike some CROs, we don’t have to rely on per-page pricing that can really escalate costs.

Extend Your Pipeline With Our Help in Phase III Studies

We’re ready to support your drug candidate at every stage of development. Our team of stress free study delivery experts also has extensive experience in early-phase and Phase IV trials.

Are you ready to learn more about our unique approach to Phase III studies? Contact us today to speak with a member of our team.